Atrial Fibrillation

Non-vitamin K antagonist oral anticoagulants may be safe, effective

Non-vitamin K antagonist oral anticoagulants may be safe, effective

By

Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.

Women with atrial fibrillation have higher risk of CVD, mortality compared with men

Women with atrial fibrillation have higher risk of CVD, mortality compared with men

By

Women with atrial fibrillation are at higher risk for cardiovascular disease, stroke, and death.

Personalizing anticoagulant treatments for nonvalvular atrial fibrillation

Personalizing anticoagulant treatments for nonvalvular atrial fibrillation

Multiple considerations come into play when choosing anticoagulant therapy for a patient with atrial fibrillation, a condition that greatly increases the risk for stroke.

Atrial fibrillation linked to central sleep apena, disordered sleep breathing in older men

Atrial fibrillation linked to central sleep apena, disordered sleep breathing in older men

Incident atrial fibrillation in older men can be predicted by central sleep apnea but not by obstructive apnea or hypoxemia.

New guideline established for managing supraventricular tachycardia

New guideline established for managing supraventricular tachycardia

The American College of Cardiology has published a guideline for the management of supraventricular tachycardia (SVT) in adult patients.

Anticoagulant use for atrial fibrillation

Anticoagulant use for atrial fibrillation

By

Anticoagulants are associated with an increased risk for bleeding, but for most patients, the benefits outweigh the bleeding risk.

Percutaneous closure of left atrial appendage may decrease mortality, hemorrhagic stroke risk

Percutaneous closure of left atrial appendage may decrease mortality, hemorrhagic stroke risk

By

Antithrombotic therapy is consistently recommended for most patients with atrial fibrillation and until recently warfarin, a vitamin K antagonist, has been the antithrombotic of choice.

Digoxin for A-fib ups deaths, hospitalizations

Digoxin for A-fib ups deaths, hospitalizations

By

In patients with atrial fibrillation but no heart failure, digoxin increases the risk of death and hospitalization.

Self pulse-monitoring may prevent second stroke

Self pulse-monitoring may prevent second stroke

Patients were taught to identify atrial fibrillation by measuring the peripheral pulse at the radial artery to prevent a second stroke.

Listening saved a life

Listening saved a life

After listening to a patient, this clinician urged an in-person visit that led to an ED admission for atrial fibrillation and heart failure.

ACC/AHA issue new A fib management guidelines

ACC/AHA issue new A fib management guidelines

Recommendations provide guidance for new medications, use of radiofrequency ablation.

Weight loss cuts A-fib events in obese patients

Weight loss cuts A-fib events in obese patients

Intensive intervention results in more weight loss, greater reduction in symptom burden.

First steps when treating atrial fibrillation

Medication, ablation or rate control for a patient with first onset of atrial fibrillation?

Apixaban wins approval for A-fib indication

Apixaban wins approval for A-fib indication

By

The FDA has approved the oral anticoagulant drug apixaban (Eliquis) to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

AHA: Rivaroxaban lowers brain bleed risk in A-fib

AHA: Rivaroxaban lowers brain bleed risk in A-fib

Patients with atrial fibrillation treated with rivaroxaban had a lower risk for intracranial hemorrhage than those treated with warfarin.

Treating atrial fibrillation during pregnancy

How often should follow-up ECG be performed on a pregnant patient with atrial fibrillation (AF) that resolves with medication that is then discontinued?

New atrial fibrillation guidelines simplify primary care treatment

New atrial fibrillation guidelines simplify primary care treatment

Atrial fibrillation (AF) affects an estimated 2.3 million Americans and is becoming more widespread as the population ages. Read about guideline changes that simplify treating AF in primary care.

Sign Up for Free e-newsletters